Based on the Evofem Biosciences Inc stock forecast from 0 analysts, the average analyst target price for Evofem Biosciences Inc is not available over the next 12 months. Evofem Biosciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Evofem Biosciences Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Evofem Biosciences Inc’s stock price was USD 0.01. Evofem Biosciences Inc’s stock price has changed by +0.00% over the past week, +12.50% over the past month and -40.00% over the last year.
No recent analyst target price found for Evofem Biosciences Inc
No recent average analyst rating found for Evofem Biosciences Inc
Company Overview Evofem Biosciences Inc
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California. Read Less
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in t...Read More
Frequently Asked Questions About Evofem Biosciences Inc (EVFM) Stock
Stock Target Advisor's fundamental analysis for Evofem Biosciences Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on EVFM's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on EVFM's stock to indicate what its average analyst target is.
EVFM stock's Price/Earning ratio is 0.00.
Our analysis grades EVFM stock's Price / Earning ratio at A. This means that EVFM stock's Price/Earning ratio is above 5.000000000000004% of the stocks in the Biotechnology sector in the OTC exchange.
Based on this EVFM may be undervalued for its sector.
The last closing price of EVFM's stock was USD 0.01.
The most recent market capitalization for EVFM is USD 1.13M.
Unfortunately we do not have enough analyst data on EVFM's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Evofem Biosciences Inc's stock.
As per our most recent records Evofem Biosciences Inc has 32 Employees.
Evofem Biosciences Inc's registered address is 7770 Regents Roas, San Diego, CA, United States, 92122.
You can get more information about it from Evofem Biosciences Inc's website at https://www.evofem.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Evofem Biosciences Inc (EVFM) Stock
Stock Target Advisor's fundamental analysis for Evofem Biosciences Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on EVFM's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on EVFM's stock to indicate what its average analyst target is.
EVFM stock's Price/Earning ratio is 0.00.
Our analysis grades EVFM stock's Price / Earning ratio at A. This means that EVFM stock's Price/Earning ratio is above 5.000000000000004% of the stocks in the Biotechnology sector in the OTC exchange.
Based on this EVFM may be undervalued for its sector.
The last closing price of EVFM's stock was USD 0.01.
The most recent market capitalization for EVFM is USD 1.13M.
Unfortunately we do not have enough analyst data on EVFM's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Evofem Biosciences Inc's stock.
As per our most recent records Evofem Biosciences Inc has 32 Employees.
Evofem Biosciences Inc's registered address is 7770 Regents Roas, San Diego, CA, United States, 92122.
You can get more information about it from Evofem Biosciences Inc's website at https://www.evofem.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EVFM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
